Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: March 1, 2007
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2006.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on March 1, 2007, to announce the aforementioned financial results.
Legal Disclaimer: The information in this Current Report and the attached Exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section, except as expressly set forth by specific reference in other filings.
Important Facts for Investor Verification
- Verify the specific revenue and net income figures for the quarter and year ended December 31, 2006, by reviewing Exhibit 99.1 (Press Release).
- Confirm the Company's liquidity position and debt levels as detailed in the referenced press release.
- Note that this 8-K serves primarily as a notification of the results announcement rather than a source of detailed financial data.